162 related articles for article (PubMed ID: 22367706)
1. Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?
Glynne-Jones R; Anyamene N; Moran B; Harrison M
Ann Oncol; 2012 Oct; 23(10):2517-2526. PubMed ID: 22367706
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum.
Glynne-Jones R; Hava N; Goh V; Bosompem S; Bridgewater J; Chau I; Gaya A; Wasan H; Moran B; Melcher L; MacDonald A; Osborne M; Beare S; Jitlal M; Lopes A; Hall M; West N; Quirke P; Wong WL; Harrison M;
BMC Cancer; 2015 Oct; 15():764. PubMed ID: 26493588
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
Glynne-Jones R; Grainger J; Harrison M; Ostler P; Makris A
Br J Cancer; 2006 Feb; 94(3):363-71. PubMed ID: 16465172
[TBL] [Abstract][Full Text] [Related]
4. Locally advanced rectal cancer: a comparison of management strategies.
Glynne-Jones R; Kronfli M
Drugs; 2011 Jun; 71(9):1153-77. PubMed ID: 21711061
[TBL] [Abstract][Full Text] [Related]
5. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
Ceelen WP; Van Nieuwenhove Y; Fierens K
Cochrane Database Syst Rev; 2009 Jan; (1):CD006041. PubMed ID: 19160264
[TBL] [Abstract][Full Text] [Related]
6. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer.
Gollins S
Colorectal Dis; 2010 Aug; 12 Suppl 2():2-24. PubMed ID: 20618363
[TBL] [Abstract][Full Text] [Related]
7. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
De Caluwé L; Van Nieuwenhove Y; Ceelen WP
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006041. PubMed ID: 23450565
[TBL] [Abstract][Full Text] [Related]
10. Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer.
Jalil O; Claydon L; Arulampalam T
J Gastrointest Cancer; 2015 Sep; 46(3):219-36. PubMed ID: 26133151
[TBL] [Abstract][Full Text] [Related]
11. Locally advanced rectal cancer: what is the evidence for induction chemoradiation?
Glynne-Jones R; Harrison M
Oncologist; 2007 Nov; 12(11):1309-18. PubMed ID: 18055850
[TBL] [Abstract][Full Text] [Related]
12. Alternative clinical end points in rectal cancer--are we getting closer?
Glynne-Jones R; Mawdsley S; Pearce T; Buyse M
Ann Oncol; 2006 Aug; 17(8):1239-48. PubMed ID: 16873440
[TBL] [Abstract][Full Text] [Related]
13. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
14. The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision.
Roselló S; Papaccio F; Roda D; Tarazona N; Cervantes A
Cancer Treat Rev; 2018 Feb; 63():156-171. PubMed ID: 29407455
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis.
Ceelen W; Fierens K; Van Nieuwenhove Y; Pattyn P
Int J Cancer; 2009 Jun; 124(12):2966-72. PubMed ID: 19253365
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
Glynne-Jones R; Mawdsley S; Novell JR
Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
[TBL] [Abstract][Full Text] [Related]
17. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Neoadjuvant FOLFOX Therapy Without Radiotherapy for Baseline Resectable Rectal Cancer.
Koizumi M; Yamada T; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Hara K; Ohta K; Uchida E; Yoshida H
In Vivo; 2018; 32(4):937-943. PubMed ID: 29936483
[TBL] [Abstract][Full Text] [Related]
19. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
20. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
